Galvin Legal, PLLC is launching an investigation on behalf of investors who suffered losses investing in Achaogen Inc. (AKAOQ) at the recommendation of their financial advisor. If you suffered losses investing in Achaogen Inc. (AKAOQ), then Galvin Legal, PLLC may be able to help you recover your losses in a Financial Industry Regulatory Authority (“FINRA“) arbitration claim against the brokerage firm that recommended the investment.
On April 15, 2019, Achaogen Inc. (AKAOQ), a biopharmaceutical company that develops and commercializes innovative antibacterial agents to address multi-drug resistant gram-negative infections, filed for bankruptcy protection, according to a press announcement.
FINRA requires brokerage firms to conduct due diligence on investments and to conduct a suitability analysis when recommending securities to a customer that takes into account the customer’s knowledge and experience. Brokerage firms that fail to conduct adequate due diligence or that make unsuitable recommendations can be held responsible for the customer’s losses in a FINRA arbitration claim.
This information is all publicly available and is being provided to you by Galvin Legal, PLLC.
Galvin Legal, PLLC is a national securities arbitration, securities mediation, securities litigation, securities fraud, securities regulation and compliance, and investor protection law practice. For more information on Galvin Legal, PLLC and its representation of investors, please visit www.galvinlegal.com or call 1-800-405-5117.